메뉴 건너뛰기




Volumn 15, Issue 7, 2004, Pages 1079-1085

Solid tumors in patients treated for Hodgkin's disease: A report from the German Hodgkins lymphoma Study Group

Author keywords

Hodgkin's lymphoma; Risk factors; Secondary solid tumors

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE;

EID: 4143080389     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh273     Document Type: Article
Times cited : (70)

References (30)
  • 1
    • 0029844258 scopus 로고    scopus 로고
    • The management of Hodgkin's disease: Half a century of change. The Kaplan memorial lecture
    • Rosenberg S. The management of Hodgkin's disease: half a century of change. The Kaplan memorial lecture. Ann Oncol 1996; 7: 555-560.
    • (1996) Ann. Oncol. , vol.7 , pp. 555-560
    • Rosenberg, S.1
  • 2
    • 0037089650 scopus 로고    scopus 로고
    • Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger
    • Ng AK, Bernardo MP, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 2101-2108
    • Ng, A.K.1    Bernardo, M.P.2    Weller, E.3
  • 3
    • 0142121297 scopus 로고    scopus 로고
    • Long-term cause-specific mortality of patients treated for Hodgkin's disease
    • Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21: 3431-3439.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 3431-3439
    • Aleman, B.M.1    van den Belt-Dusebout, A.W.2    Klokman, W.J.3
  • 4
    • 0026447595 scopus 로고
    • Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease
    • Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol 1992; 3(Suppl 4): 117-128.
    • (1992) Ann. Oncol. , vol.3 , Issue.SUPPL. 4 , pp. 117-128
    • Henry-Amar, M.1
  • 5
    • 0023835089 scopus 로고
    • Risk of second cancers after treatment for Hodgkin's disease
    • Tucker M, Coleman C, Cox R. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
    • (1988) N. Engl. J. Med. , vol.318 , pp. 76-81
    • Tucker, M.1    Coleman, C.2    Cox, R.3
  • 6
    • 0028329713 scopus 로고
    • Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage
    • van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12: 1063-1073.
    • (1994) J. Clin. Oncol. , vol.12 , pp. 1063-1073
    • van Leeuwen, F.E.1    Chorus, A.M.2    van den Belt-Dusebout, A.W.3
  • 7
    • 0142058040 scopus 로고    scopus 로고
    • Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group
    • Josting A, Wiedenmann S, Franklin J et al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003; 21: 3440-3446.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 3440-3446
    • Josting, A.1    Wiedenmann, S.2    Franklin, J.3
  • 8
    • 0035300679 scopus 로고    scopus 로고
    • Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
    • Rueffer U, Josting A, Franklin J et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol 2001; 19: 2026-2032.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 2026-2032
    • Rueffer, U.1    Josting, A.2    Franklin, J.3
  • 9
    • 0031927630 scopus 로고    scopus 로고
    • The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment
    • Enrici R, Anselmo A, Iacari V et al. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment. Haematologica. 1998; 83: 636-644.
    • (1998) Haematologica , vol.83 , pp. 636-644
    • Enrici, R.1    Anselmo, A.2    Iacari, V.3
  • 10
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 34: 457-464.
    • (1958) J. Am. Stat. Assoc. , vol.34 , pp. 457-464
    • Kaplan, E.1    Meier, P.2
  • 11
    • 0033952110 scopus 로고    scopus 로고
    • Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
    • van Leeuwen FE, Klokman WJ, Veer MB et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18: 487-497.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 487-497
    • van Leeuwen, F.E.1    Klokman, W.J.2    Veer, M.B.3
  • 12
    • 0033974306 scopus 로고    scopus 로고
    • Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment
    • Swerdlow AJ, Barber JA, Hudson GV et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498-509.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 498-509
    • Swerdlow, A.J.1    Barber, J.A.2    Hudson, G.V.3
  • 13
    • 0037102360 scopus 로고    scopus 로고
    • Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
    • Dores GM, Metayer C, Curtis RE et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-3494.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 3484-3494
    • Dores, G.M.1    Metayer, C.2    Curtis, R.E.3
  • 14
    • 0034088026 scopus 로고    scopus 로고
    • Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
    • Metayer C, Lynch CF, Clarke EA et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000; 18: 2435-2443.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 2435-2443
    • Metayer, C.1    Lynch, C.F.2    Clarke, E.A.3
  • 15
    • 0034128929 scopus 로고    scopus 로고
    • Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence
    • Green DM, Hyland A, Barcos MP et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 2000; 18: 1492-1499.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 1492-1499
    • Green, D.M.1    Hyland, A.2    Barcos, M.P.3
  • 16
    • 0036862103 scopus 로고    scopus 로고
    • Long-term risk of second malignancy after treatment of Hodgkin's disease: The influence of treatment, age and follow-up time
    • Foss Abrahamsen A, Andersen A, Nome O et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002; 13: 1786-1791.
    • (2002) Ann. Oncol. , vol.13 , pp. 1786-1791
    • Foss Abrahamsen, A.1    Andersen, A.2    Nome, O.3
  • 17
    • 0342905432 scopus 로고    scopus 로고
    • Second malignancies after Hodgkin's disease: The Munich experience
    • Munker R, Grutzner S, Hiller E et al. Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol 1999; 78: 544-554.
    • (1999) Ann. Hematol. , vol.78 , pp. 544-554
    • Munker, R.1    Grutzner, S.2    Hiller, E.3
  • 18
    • 0029877511 scopus 로고    scopus 로고
    • Breast cancer and other second neoplasms after childhood Hodgkin's disease
    • [see comments]
    • Bhatia S, Robison L, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-751 [see comments].
    • (1996) N. Engl. J. Med. , vol.334 , pp. 745-751
    • Bhatia, S.1    Robison, L.2    Oberlin, O.3
  • 19
    • 0041963074 scopus 로고    scopus 로고
    • Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    • van Leeuwen FE, Klokman WJ, Stovall M et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003; 95: 971-980.
    • (2003) J. Natl. Cancer Inst. , vol.95 , pp. 971-980
    • van Leeuwen, F.E.1    Klokman, W.J.2    Stovall, M.3
  • 20
    • 0027535978 scopus 로고
    • Breast cancer after treatment of Hodgkin's disease
    • Hancock S, Tucker M, Hoppe R. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85: 25-31.
    • (1993) J. Natl. Cancer Inst. , vol.85 , pp. 25-31
    • Hancock, S.1    Tucker, M.2    Hoppe, R.3
  • 21
    • 0026482443 scopus 로고
    • Lung cancer following Hodgkin's disease: A case-control study
    • Kaldor J, Day N, Bell J et al. Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 1992; 52: 677-681.
    • (1992) Int. J. Cancer , vol.52 , pp. 677-681
    • Kaldor, J.1    Day, N.2    Bell, J.3
  • 22
    • 0026560447 scopus 로고
    • Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation
    • Swerdlow A, Douglas A, Hudson G et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 1992; 304: 1137-1143.
    • (1992) Br. Med. J. , vol.304 , pp. 1137-1143
    • Swerdlow, A.1    Douglas, A.2    Hudson, G.3
  • 23
    • 0028154066 scopus 로고
    • Second cancer risk following Hodgkin's disease: A 20-year follow-up study
    • van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312-325.
    • (1994) J. Clin. Oncol. , vol.12 , pp. 312-325
    • van Leeuwen, F.E.1    Klokman, W.J.2    Hagenbeek, A.3
  • 24
    • 0037105618 scopus 로고    scopus 로고
    • Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors
    • Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 1989-1996.
    • (2002) Blood , vol.100 , pp. 1989-1996
    • Ng, A.K.1    Bernardo, M.V.2    Weller, E.3
  • 25
    • 0031405592 scopus 로고    scopus 로고
    • Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients
    • Cutuli B, Dhermain F, Borel C et al. Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer 1997; 33: 2315-2320.
    • (1997) Eur. J. Cancer , vol.33 , pp. 2315-2320
    • Cutuli, B.1    Dhermain, F.2    Borel, C.3
  • 26
    • 1842287357 scopus 로고    scopus 로고
    • Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome
    • Mauch P, Kalish L, Marcus K et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87: 3625-3632.
    • (1996) Blood , vol.87 , pp. 3625-3632
    • Mauch, P.1    Kalish, L.2    Marcus, K.3
  • 27
    • 0027082879 scopus 로고
    • Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients
    • [see comments]
    • Yahalom J, Petrek J, Biddinger P et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992; 10: 1674-1681 [see comments].
    • (1992) J. Clin. Oncol. , vol.10 , pp. 1674-1681
    • Yahalom, J.1    Petrek, J.2    Biddinger, P.3
  • 28
    • 0031972611 scopus 로고    scopus 로고
    • Current perspectives on radiation-induced breast cancer
    • [see comments]
    • Goss P, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol 1998; 16: 338-347[see comments].
    • (1998) J. Clin. Oncol. , vol.16 , pp. 338-347
    • Goss, P.1    Sierra, S.2
  • 29
    • 0027057038 scopus 로고
    • Radiation-associated breast cancer after Hodgkin's disease: Risks and screening in perspective
    • [editorial; comment]
    • Shapiro C, Mauch P. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective. J Clin Oncol 1992; 10: 1662 -1665[editorial; comment].
    • (1992) J. Clin. Oncol. , vol.10 , pp. 1662-1665
    • Shapiro, C.1    Mauch, P.2
  • 30
    • 0037028736 scopus 로고    scopus 로고
    • Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    • Travis LB, Gospodarowicz M, Curtis RE et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94: 182-192.
    • (2002) J. Natl. Cancer Inst. , vol.94 , pp. 182-192
    • Travis, L.B.1    Gospodarowicz, M.2    Curtis, R.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.